Ache Itches to Go Public

Ache Itches to Go Public

Equity

Amid growing investor appetite for an IPO from the still untapped Brazil pharmaceutical industry, Ache, one of the country’s leading drug companies, is heard in advanced talks to go public. Brazil’s largest investors, including portfolio managers at Itau-Unibanco Asset Management (IUAM) and Bradesco Asset Management (BRAM), say a substantial, well-run company from that sector would draw significant interest. “Pharmaceutical companies all over the world are listed but here in Brazil we still don’

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial